Biosimilars should be routinuely assessed by NICE, says ABPI
Calls for biosimilars to go through full HTA process
Read More
Section: Regulatory
EMA publishes drug shortages plan
Globalisation of manufacturing among key issues to address
Read More
Pharma industry challenges Germany’s drug pricing policy
Says mandatory discounts and price freezes on drugs are no longer justified
Read More
India approves national drug pricing scheme
Adds around 350 new drugs to the country’s essential medicines list
Read More
Ranbaxy recalls generic Lipitor in US
Several batches withdrawn after some products found to contain small particles of glass
Read More